Trial Details

WITHDRAWN
Basic Information
Clinical ID c4241
Identifier NCT00801125
Trial Title Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2008-12
Primary Completion Date 2010-05
Completion Date -